Livemint

Decoded: Why Indias $130 billion pharma ambition faces a hurdle as investigation backlogs delay drug batch releases

A Vector Consulting Group study finds that 80% of surveyed pharmaceutical manufacturing professionals reported batch-release delays due to open investigations, highlighting how incident backlogs, documentation requirements and supervisory constraints can affect factory productivity.